Phase 1 Norwalk Vaccine Study
Clinical trial NCT00806962 · COMPLETED
Trial details
- NCT number
- NCT00806962
- Sponsor
- LigoCyte Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2009-10-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.